The latest updates on thoughts, works, and stories
Welcome to this week’s regional edition of Outbreak Outlook! It is only available to paid subscribers. If you wish to become a paid subscriber and access region-specific information, please
Welcome to this week’s regional edition of Outbreak Outlook! It is only available to paid subscribers. If you wish to become a paid subscriber and access region-specific information, please
Welcome to this week’s regional edition of Outbreak Outlook! It is only available to paid subscribers. If you wish to become a paid subscriber and access region-specific information, please
Influenza and RSV remain stubbornly high
Welcome to this week’s regional edition of Outbreak Outlook! It is only available to paid subscribers. If you wish to become a paid subscriber and access region-specific information, please
The first edition of FOI Clinical is live. It went out to inboxes this morning. You can also access it online here. This week’s issue covers measles clusters, pertussis
Moderna announced this evening that the Food and Drug Administration (FDA) has refused to initiate a review of its application for an mRNA-based seasonal influenza vaccine. There are multiple reasons
Welcome to the Southern edition of Outbreak Outlook. It is only available to paid subscribers. If you wish to become a paid subscriber and access region-specific information, click the Subscribe
All three major respiratory diseases are hanging around stubbornly
Welcome to this week’s regional edition of Outbreak Outlook! It is only available to paid subscribers. If you wish to become a paid subscriber and access region-specific information, please
Welcome to the Midwestern edition of Outbreak Outlook. It is only available to paid subscribers. If you wish to become a paid subscriber and access region-specific information, click the Subscribe
Welcome to the Northeastern edition of Outbreak Outlook. It is only available to paid subscribers. If you wish to become a paid subscriber and access region-specific information, click the Subscribe
